1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function

Overview of attention for article published in BMC Pharmacology and Toxicology, September 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 11 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

DUAL INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 AND TDO) AND THEIR USE IN THERAPY

Application WO-2023166492-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.